🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A phase II clinical trial of neoadjuvant sasanlimab and SBRT as an in situ vaccine for cisplatin-ineligible muscle invasive #BladderCancer. Presented by Raj Satkunasivam Houston Methodist Urology and Residency Program. #EAU24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/4apa3Xs European Association of Urology (EAU)

We are back with our 4th Annual Collaborative Urologic Research Symposium (CUReS) in partnership w/ BCM Department of Urology, University of Texas Houston Urology, Texas A&M Medicine & UTMBUrology on August 7th at the HMH Research Institute Save the date & spread the word! 🪩🤗 Register Here: learn.houstonmethodist.org/cures-2024#gro…

🥳 Houston just had its 1st #VAPOR2 procedure! Thanks to Raj Satkunasivam & team at Houston Houston Methodist for working to #Vanquish #ProstateCancer in a way that is #GentleOnPatients, #ToughOnCancer 💪 💦 More about #CancerAblationByWaterVapor at francismedical.com #FocalTherapy

This week, Raj Satkunasivam Rose Khavari MD Houston Methodist Urology and Residency Program meet with #urology legend Timothy Boone, MD, PhD, DSc (hon) to discuss how humanism and empathy can improve career satisfaction and patient care Kathleen Kobashi Akhil Muthigi, MD Mohit Khera Angie Smith @urodoco #URO185 open.spotify.com/episode/1wYqZl…

It was so fun to present updates on #bladdercancer to Urology residents Houston Methodist on 8/22; thanks Keith Syson Chan Lab Raj Satkunasivam for the invite! Great prep for amazing IBCG meeting! Pavlos Msaouel Ashish M. Kamat, MD, MBBS Omar Alhalabi, MD Eleni Efstathiou Hsieh Lab Fred Hutch Cancer Center Dr. Bishoy M. Faltas

For those going to the operating room on this Friday the 13th, a little reassurance! Raj Satkunasivam Carlos Riveros journals.lww.com/aosopen/fullte…

Perioperative durvalumab + neoadjuvant chemo & cystectomy in operable bladder cancer significantly delays (HR 0.68) event free survival and a 25% reduction in the risk of death. 10% ⬆️ pCR. It’s the 1st time immune therapy has an OS benefit in muscle invasive UC #ESM024 NEJM

Big excitement #esmo24 regarding peri-op immunotherapy with data from NIAGARA and AMBASSADOR. Today, our aggregate data is out showing a particular benefit to adjuvant therapy in bladder cancer, with unclear benefits in upper tract sciencedirect.com/science/articl… Aly-Khan Lalani Raj Satkunasivam

🧵 Thrilled to share our new research in JAMA. We report industry payments to peer reviewers of top medical journals @BMJ_latest, JAMA, The Lancet, and NEJM. 💰 jamanetwork.com/journals/jama/… #AcademicPublishing Univ of Toronto Urology U of T Department of Surgery @IHPMEuoft

Meta-analysis of adjuvant PD1/L1 inhibitor immunotherapy in MIBC - Guru P. Sonpavde, MD AdventHealth Central Florida Raj Satkunasivam Houston Methodist Urology and Residency Program oncodaily.com/url/179679 #Cancer #BladderCancer #MIBC #ImmuneOnc #IO #ImmunoOncology #Immunotherapy #MedEd #MedNews #Health #Medicine #OncoDaily #Oncology

JUST IN: + pivotal trial for PD-1 in non-muscle invasive bladder cancer (NMIBC): The CREST trial of BCG +/- PD-1 sasanlimab in BCG-naïve, high-risk NMIBC met 1EP of EFS. This could signal a major shift in the bladder cancer field, and in "early stage" solid cancers in general.

Thrilled to welcome y’all to Houston for the 20th annual Shelby Webster #TestisCa Consortium. Pls amplify! Houston Methodist Urology and Residency Program Nabil Adra Daniel Lin james mckiernan Craig Nichols Seth Lerner 4.5⭐️ Long Snapper CO/26 Scott Eggener Jaime Landman Raj Satkunasivam Dharam Kaushik [email protected] DrBagrodia John W. Davis, MD

Great work Sanjana Ranganathan Carlos Riveros Vatsala Mundra! Houston Methodist Urology and Residency Program Yusuke Tsugawa Natalie Coburn Angela Jerath MD, MSc Allan Detsky MD PhD CM Christopher Wallis (he/him/his)

Surgery Just Before The Weekend? Bad Idea, Study Says usnews.com/news/health-ne… Houston Methodist MD Houston Methodist

🚨OPTIMUM trial results #EAU25 Multicentre RCT (n=802) MRI-TB vs MicroUS vs MicroUS+MRI-TB in men with suspected PCa. MicroUS non-inferior for GG2 detection. Possible alternative to MRI-TB? Copublished in JAMA jamanetwork.com/journals/jama/…

We are looking for a research coordinator to join our team! Immensely supportive group. Join a great team of research personnel working on interventional trials in urologic oncology. Many options for a career and professional development. houstonmethodistcareers.org/job/105816/res…

Xi Robot Assisted Radical Cysto-prostatectomy w Bilateral Nerve Sparing (Unedited) youtu.be/MgNhkStu4Jk?si… via YouTube

Xi Robot Assisted Bilateral Extended PLND during Radical Cystectomy for MIBC (unedited) youtu.be/uiICwu2khrE?si… via YouTube

We tested the feasibility and immunogenicity of a personalized neoantigen vaccine + PD-L1 blockade in #bladdercancer including the adjuvant setting. nature.com/articles/s4301… Jon Anker, MD, PhD Bhardwaj Lab UroToday.com Uromigos The Tisch Cancer Institute Dr. Bishoy M. Faltas Nature Cancer Bladder Cancer Advocacy Network